What We’ve Funded

EveryCat-supported health studies have helped veterinarians improve the diagnosis and treatment of many diseases and conditions, changing the way feline medicine is practiced. Read about the grants we’ve funded below.

Search Our Past Grants

Name of Grant

Description

W21-042: Hormonal regulation of appetite in cats with and without chronic kidney disease

Maintaining good nutrition is a vital component in the overall care of cats with chronic kidney disease (CKD). Appetite is

W21-035: Creation of a Feline Living Bioarchive and Feline Induced Pluripotent Stem Cells for Use in Investigations into Feline Tooth Resorption & Other Feline Diseases

Cats commonly suffer from a dental disease called tooth resorption (TR). It is caused by odontoclasts; cells that are normally

W21-032: Glucagon-like peptide 2 in cats with inflammatory bowel disease

Inflammatory bowel disease (IBD) is the most common cause of long-standing vomiting and diarrhea in cats. Treatment options are limited,

W21-030: Intestinal S100/CALGRANULIN Expression in Cats With Chronic Enteropathy – Paving the Way For Novel Non-invasive Biomarkers and Pathway-specific Treatment Options

Chronic gastrointestinal inflammation in cats is a complex condition associated with an exaggerated immune re-sponse, but the exact cause of

W21-028: Comparison of Echocardiography and Biomarkers in Cats Eating High- or Low-Pulse Diets

Dilated cardiomyopathy (DCM) is a progressive and usually fatal disease in which the heart muscle becomes weak, leading to an

W21-018: Determining the clinical efficacy and safety of remdesivir for the treatment of naturally occurring feline infectious peritonitis

Feline infectious peritonitis (FIP) is a fatal coronaviral disease that affects cats around the world. Despite significant advances in research

W21-017: Use of a liposome-toll-like receptor complex (LTC) immune stimulant in the treatment of effusive FIP – A clinical trial

The main goal of this study is to determine the potential efficacy of a new immune stimulant (LTC) for treatment

W21-015: Effects of early life experiences on later problematic behaviors in rescued, fostered, shelter kittens

Behavior problems in cats decrease adoptions and increase returns and euthanasia in shelter cats. In owned cats, early separation from

W21-010: Development of a Rapid CRISPR CasRx Diagnostic Tool for Feline Infectious Peritonitis

Feline infectious peritonitis (FIP) is a devastating disease of cats that, up until recently, has been uniformly fatal. FIP occurs

W21-007: Feline peritoneal- and ascites-associated macrophages in health and in cats with feline infectious peritonitis: leveraging an anticoronaviral clinical trial

Feline infectious peritonitis (FIP), caused by the mutant feline coronavirus known as FIPV, is a relatively common and generally lethal

W21-006: Determining the invitro intrinsic clearance (feline microsomes) and in vivo pharmacokinetic profile of remdesivir in cats with naturally occurring feline infectious peritonitis (FIP

Feline infectious peritonitis (FIP) is a coronavirus disease that affects domestic and wild cats worldwide.[3] The disease results in accumulation

W21-002: Whole Exome Sequencing to Identify Candidate Gene and Immunotherapy Treatment Options in Feline Oral Squamous Cell Carcinoma

The genetics of cat cancers are poorly understood. The recent advancements that have improved survival outcomes in human cancers, including

MT21-014: Determining the genetics underlying diabetes mellitus in the domestic cat

Diabetes is one of the most common cat diseases diagnosed by veterinarians in the USA. It is due to the

MT21-013: Investigating Pectus Excavatum in Cats Using Rigorous Phenotyping and Population-Scale High- Throughput Sequencing

Thoracic deformity in domestic cats shows a considerable bias in breeds but is present across all. Multiple conditions are often

MT21-012: Precision Medicine Genomics for Cats (using the new cat reference genome) *continuation study

Precision/Genomic Medicine using genetic information of an individual to determine the cause of a specific health problem, which is the

MT21-010: Non-genetic enhancement of feline adipose mesenchymal stromal cell immunomodulation with adenosine-loaded nanoparticles

Approximately 0.7-12% of domestic cats nationwide suffer from gingivostomatitis (inflammation of gums and oral mucosa). This disease results in severe

MT21-006: The Prognostic Value of Circulating Galectin-3 in Feline Heart Failure

Cats are commonly affected by cardiovascular disease. Worldwide estimates indicate that greater than 10% of cats have an underlying heart

MT21-005: Prospective evaluation of unlicensed GS-441524-like antiviral therapy for treatment of feline infectious peritonitis

Feline infectious peritonitis (FIP) is a common, viral disease affecting cats worldwide. Until very recently, FIP was considered uniformly fatal

MT21-003: The role of microbial indole catabolites of tryptophan in host-microbiome cross-talk in cats with chronic enteropathies

Inflammatory bowel disease (IBD) and small cell lymphoma (SCL) are chronic gastrointestinal disorders that negatively impact survival and quality of

MT21-001: Impact of the secondary bile acid ursodeoxycholic acid (Ursodiol) on the feline gut microbiota and metabolome

Ursodiol is an FDA approved naturally occurring bile acid that is used to treat a variety of liver and gastrointestinal

Want to learn more about what we support?

View Our Past Research Grants

Make your own impact.

Support Cat Health Submit a Research Proposal